Natco Pharma is trading around ₹850, holding well above its recent breakout zone. The stock is sustaining above the 20-day EMA, while the 50-day EMA near ₹820 is acting as a strong support. RSI (14) is around 60, suggesting bullish momentum with more room for upside. MACD is positive, indicating trend strength. Immediate support is placed at ₹830–820, while resistance lies at ₹870–880. A breakout above ₹880 could trigger further upside towards ₹920–940, whereas dips near ₹830 can be considered as a buying opportunity with a stop-loss below ₹810.
BUY : NATCOPHARM-EQ( NATCOPHARM ) [3918]
—
by